Unknown

Dataset Information

Perfluorocarbon nanodroplets can reoxygenate hypoxic tumors in vivo without carbogen breathing.


ABSTRACT: Nanoscale perfluorocarbon (PFC) droplets have enormous potential as clinical theranostic agents. They are biocompatible and are currently used in vivo as contrast agents for a variety of medical imaging modalities, including ultrasound, computed tomography, photoacoustic and 19F-magnetic resonance imaging. PFC nanodroplets can also carry molecular and nanoparticulate drugs and be activated in situ by ultrasound or light for targeted therapy. Recently, there has been renewed interest in using PFC nanodroplets for hypoxic tumor reoxygenation towards radiosensitization based on the high oxygen solubility of PFCs. Previous studies showed that tumor oxygenation using PFC agents only occurs in combination with enhanced oxygen breathing. However, recent studies suggest th

SUBMITTER: Xiang Y 

PROVIDER: S-EPMC6470341 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature